What Skysis, LLC does

Skysis, LLC provides integrated market access and commercial strategy solutions to the biopharmaceutical industry. Founded in 2011 and headquartered in Scottsdale, Arizona, the firm operates within the broader Avalere Health group (corporate legal name references Avalere Health Topco Limited), delivering professional services across three integrated practice areas: Advisory (market access, value, evidence, and policy consulting), Medical (medical communications and scientific storytelling), and Marketing (brand strategy and patient-centric campaigns). The group's work is guided by a proprietary strategic framework branded "SenseMaking," described as a bespoke model that integrates insights across science, society, and systems to produce unified client strategies.

Skysis and its affiliated entities serve enterprise pharmaceutical, biotechnology, and healthcare clients navigating complex regulatory environments, value demonstration requirements, and patient access barriers. Target use cases span strategic consulting on industry trends, market access and reimbursement strategy, evidence generation, medical communications, HCP engagement, brand marketing, and patient support programs. Customer segmentation is horizontal across the biopharma value chain, with deeper specialization in oncology (evidenced by the "Within Reach" anthology initiative). The firm is sales-led, with direct enterprise engagement via dedicated Advisory, Medical, and Marketing teams.

The revenue model is predominantly professional services — consulting retainers, medical communications engagements, and brand marketing campaigns — with an additional managed-services component through Data, Technology, and Media offerings. Pricing is not publicly disclosed. Geographic delivery spans the United Kingdom (London European HQ at 66 City Road), the United States (Scottsdale base plus roles in New York and Philadelphia), and Japan (full-service offering launched in 2024, led by industry veteran Junji Yokokawa). No public revenue figures, funding rounds, M&A activity, or operating status details are disclosed for Skysis, LLC specifically.

Name

Skysis, LLC

Legal name

Avalere Health Topco Limited

Website

https://skysis.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Scottsdale

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Revenue model

1. Advisory Services: Consulting services providing strategic advisory to pharma and healthcare companies on market access, value, evidence, and policy matters.
2. Medical Communications: Medical communications services creating meaningful stories and experiences that bring scientific data to life for healthcare professionals.
3. Marketing Services: Pharma marketing services building brands that thrive in an ever-changing world through authentic and relevant patient-centric campaigns.
4. Data, Technology, and Media: Data, technology solutions, and media offerings for the healthcare and pharma industry.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Skysis, LLC provides integrated market access and commercial strategy solutions to the biopharmaceutical industry. The firm supports pharmaceutical and biotech clients with consulting services focused on navigating complex market access, reimbursement, and commercialization challenges for therapeutics.

Differentiator

Problem solved

Functional benefit

Products and services

• Market Access Strategy Consulting
• Commercial Strategy Solutions

Segments3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• IQVIA: Largest biopharma services platform combining real-world data, evidence generation, and strategic consulting; competes directly with Skysis in market access and HEOR advisory while offering much broader data and delivery scale.
• Kantar Health (now part of Kantar): Global data, insights, and consulting business with significant pharma and market access work; comparable buyer base and overlapping evidence/access advisory offerings.
• McKinsey & Company (Pharma Practice): Top-tier strategy consultancy with a large pharma and healthcare practice addressing market access, launch, and commercial strategy; competes for senior-level biopharma advisory mandates Skysis also targets.
• Boston Consulting Group (Healthcare / Biopharma): Global strategy consultancy with deep biopharma practice spanning market access, value-based pricing, and launch excellence; competes for enterprise-level biopharma strategy work.

Direct peers

• ZS Associates: Global consulting firm with a large pharma/biotech practice spanning strategy, market access, and sales/marketing operations; directly comparable in service mix and client base to Skysis.
• Evidera (PPD / Thermo Fisher Scientific): Specialized market access, HEOR, and real-world evidence consultancy now under PPD/Thermo Fisher; competes with Skysis for market access strategy and value demonstration engagements with biopharma clients.
• Syneos Health Consulting: Biopharma-focused contract research and commercial organization with a consulting arm that addresses market access, launch, and commercial strategy for the same pharma/biotech buyer as Skysis.
• Precision Medicine Group (Precision AQ): Specialized biopharma services group with a market access arm (Precision AQ) offering evidence, access strategy, and communications; overlaps directly with Skysis's integrated market access and medical communications positioning.
• Trinity Partners: Biopharma-focused strategy consulting firm advising on commercial strategy, market access, and launch planning for specialty and rare disease products; a close direct peer to Skysis in size and scope.
• Charles River Associates (CRA): Life sciences practice provides economic and strategic consulting including market access, pricing, and value evidence; competes for similar biopharma advisory engagements.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Skysis, LLC